Terns Pharmaceuticals Inc (TERN) concluded trading on Thursday at a closing price of $8.34, with 3.41 million shares of worth about $28.41 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 23.56% during that period and on July 11, 2024 the price saw a gain of about 14.25%. Currently the company’s common shares owned by public are about 64.58M shares, out of which, 42.98M shares are available for trading.
Stock saw a price change of 21.57% in past 5 days and over the past one month there was a price change of 19.31%. Year-to-date (YTD), TERN shares are showing a performance of 28.51% which increased to 0.72% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $3.26 but also hit the highest price of $8.68 during that period. The average intraday trading volume for Terns Pharmaceuticals Inc shares is 1.04 million. The stock is currently trading 14.78% above its 20-day simple moving average (SMA20), while that difference is up 27.66% for SMA50 and it goes to 39.87% higher than SMA200.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Terns Pharmaceuticals Inc (NASDAQ: TERN) currently have 64.58M outstanding shares and institutions hold larger chunk of about 75.85% of that.
The stock has a current market capitalization of $539.43M and its 3Y-monthly beta is at -0.37. It has posted earnings per share of -$1.26 in the same period. It has Quick Ratio of 27.85 while making debt-to-equity ratio of 0.00. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for TERN, volatility over the week remained 9.21% while standing at 8.52% over the month.
Stock’s fiscal year EPS is expected to drop by -5.52% while it is estimated to decrease by -5.49% in next year.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Mizuho on June 22, 2023 offering a Buy rating for the stock and assigned a target price of $16 to it. Coverage by Jefferies stated Terns Pharmaceuticals Inc (TERN) stock as a Buy in their note to investors on June 07, 2023, suggesting a price target of $18 for the stock. On May 31, 2023, ROTH MKM Initiated their recommendations, while on May 08, 2023, BMO Capital Markets Initiated their ratings for the stock with a price target of $18. Stock get a Mkt outperform rating from JMP Securities on February 14, 2023.
